← All trials
NCT00734474
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2008
- Primary completion
- Jun 1, 2011
- Completion date
- Jul 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 1202
- Arms / groups
- 9 / —
- Source
- AACT · pre-existing
Sponsors
- Eli LillyLead sponsor
- Eli LillyStudy chair
- United BioSource CorporationCollaborator
- Tessella Inc.Collaborator
- Berry ConsultantsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.